IE46005B1 - Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture - Google Patents

Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture

Info

Publication number
IE46005B1
IE46005B1 IE2474/77A IE247477A IE46005B1 IE 46005 B1 IE46005 B1 IE 46005B1 IE 2474/77 A IE2474/77 A IE 2474/77A IE 247477 A IE247477 A IE 247477A IE 46005 B1 IE46005 B1 IE 46005B1
Authority
IE
Ireland
Prior art keywords
particles
active substance
pharmaceutical preparation
coating
coated
Prior art date
Application number
IE2474/77A
Other languages
English (en)
Other versions
IE46005L (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IE46005L publication Critical patent/IE46005L/xx
Publication of IE46005B1 publication Critical patent/IE46005B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE2474/77A 1976-12-07 1977-12-06 Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture IE46005B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655331 DE2655331A1 (de) 1976-12-07 1976-12-07 Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IE46005L IE46005L (en) 1978-06-07
IE46005B1 true IE46005B1 (en) 1983-01-26

Family

ID=5994862

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2474/77A IE46005B1 (en) 1976-12-07 1977-12-06 Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture

Country Status (15)

Country Link
JP (1) JPS5372815A (es)
AT (1) AT355216B (es)
AU (1) AU513409B2 (es)
BE (1) BE861608A (es)
DE (1) DE2655331A1 (es)
DK (1) DK542877A (es)
ES (1) ES464642A1 (es)
FR (1) FR2373280A1 (es)
GB (1) GB1569018A (es)
IE (1) IE46005B1 (es)
IL (1) IL53539A0 (es)
NL (1) NL7713392A (es)
NZ (1) NZ185855A (es)
PT (1) PT67370B (es)
ZA (1) ZA777204B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243891B1 (en) * 1986-04-29 1991-08-14 Hoechst-Roussel Pharmaceuticals Incorporated A laminar structure for administering a chemical at a controlled release rate
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DK0812320T3 (da) * 1995-02-22 2003-04-14 Aventis Pharma Ltd Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE33874B1 (en) * 1968-12-24 1974-11-27 Leo Pharm Prod Ltd New sulphamyl-benzoic acid derivatives

Also Published As

Publication number Publication date
PT67370A (de) 1978-01-01
DE2655331A1 (de) 1978-06-08
BE861608A (fr) 1978-06-07
IL53539A0 (en) 1978-03-10
NL7713392A (nl) 1978-06-09
ATA873777A (de) 1979-07-15
NZ185855A (en) 1979-10-25
ES464642A1 (es) 1978-09-01
GB1569018A (en) 1980-06-11
AU513409B2 (en) 1980-11-27
PT67370B (de) 1979-09-20
AT355216B (de) 1980-02-25
ZA777204B (en) 1978-10-25
FR2373280A1 (fr) 1978-07-07
DK542877A (da) 1978-06-08
AU3127477A (en) 1979-06-14
FR2373280B1 (es) 1980-06-20
IE46005L (en) 1978-06-07
JPS5372815A (en) 1978-06-28

Similar Documents

Publication Publication Date Title
US4083949A (en) New oral form of medicament and a method for producing it
US5370880A (en) Pharmaceutical formulations containing acrivastine
DE69208299T2 (de) Feste Arzneizubereitungen zur oralen Verabreichung mit verlängerter Magenverweilzeit
CA2281420C (en) Preparation of pharmaceutically-active granules
AU709887B2 (en) Long-lasting release Nifedipine preparation
JP2535339B2 (ja) 活性物質の制御速度制御用装置
US4533540A (en) Nitroglycerin-containing polymeric matrix for sustained release on topical application
RU2127587C1 (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, (варианты) и способ их получения
CA2265766C (en) Rapidly disintegrating pellets
JP3157182B2 (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
US4806361A (en) Medicaments in sustained release unit dose form
US5275825A (en) Compressed-molded preparations
AU592731B2 (en) Nitrofurantoin dosage form
JPS6323814A (ja) 経口投与形体の徐放性医薬組成物
JPH0643312B2 (ja) 薬学的調合剤
HU193359B (en) Process for preparing a delayed theophylline composition
CA1184497A (en) Pharmaceutical composition
GB1593062A (en) Coatings
KR890006240A (ko) 조절흡수 딜티아젬 제제
US20010001658A1 (en) Granule modulating hydrogel system
Karvekar et al. A brief review on sustained release matrix type drug delivery system
IE46005B1 (en) Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture
US5230901A (en) Sustained release tablet of a mixture of alginates and polyacrylates
RU2435584C2 (ru) Пролонгированная фармацевтическая композиция, лекарственная форма и способ ее изготовления (варианты)
CA2006184C (en) Prolonged release composition based on trimebutine and process for the preparation thereof